Dr Garry Laverty
Principal Investigator

Garry graduated with a First Class Honours Masters degree (MPharm) from the School of Pharmacy at Queen's University Belfast in 2005 and a PhD in Pharmaceutics in 2010. After two years working for a Biotech company, Garry returned to the School as a Lecturer and was promoted to Senior Lecturer in 2020. Garry was previously a Visiting Researcher at Bing Xu’s lab (Brandeis University, Department of Chemistry), a world-leading group researching peptide nanomaterials.

Dr Sreekanth Pentlavalli
EPSRC funded Research Fellow

Sree is involved in the development of a novel peptide-mimetic hydrogel platform for use as a long-acting injectable drug delivery systems for diseases with poor medication adherence (e.g. HIV/AIDS).

Dr Sophie Coulter
EPSRC funded Research Fellow

Sophie's work involes the study of peptide hydrogels as multifunctional materials for combined HIV prevention-contraceptive drug delivery. Sophie graduated with a First Class Honours Masters degree (MPHARM) from the School of Pharmacy at Queen's University Belfast in 2015.

Yuming An
PhD student

Yuming work involves tailoring our peptide-mimetic hydrogels to achieve long-acting drug delivery with multiple HIV and contraceptive drugs for at least 28 days.

Han Sun

Han Sun is tailoring our peptide-mimetic gels for long-acting drug delivery using several techniques including neutron scattering

OUR RESEARCH IS FUNDED BY